ARATANA THERAPEUTICS, INC.

SEC insider activity covers quarterly filings through June 30, 2026. Later filings are not included. Reported roles do not establish current employment or current holdings. SEC filing documents, sections and filing-text search cover filings dated January 1, 2000 onward. Earlier filings are deferred until after launch.

organization

SEC Insider

$86.4M

392 transactions

Summary

ARATANA THERAPEUTICS, INC. is an organization.

Recent Insider Transactions

As filed, including amendments; not net cash flow or current holdings. Joint reports count once. Totals cover known values only.

Buys: $12.1MSales: $68.3M36 insiders

Date	Insider	Type	Value
2019-07-18	Joint reporting: Broadfin Healthcare Master Fund Ltd; Broadfin Capital, LLC; KOTLER KEVIN	D	—
2019-07-18	AYRES JOHN C(SEE REMARKS)	D	—
2019-07-18	AYRES JOHN C(SEE REMARKS)	D	—
2019-07-18	AYRES JOHN C(SEE REMARKS)	D	—
2019-07-18	AYRES JOHN C(SEE REMARKS)	D	—
2019-07-18	AYRES JOHN C(SEE REMARKS)	D	—
2019-07-18	AYRES JOHN C(SEE REMARKS)	D	—
2019-07-18	AYRES JOHN C(SEE REMARKS)	D	—
2019-07-18	AYRES JOHN C(SEE REMARKS)	D	—
2019-07-18	Barbarosh Craig A.	D	—
2019-07-18	Barbarosh Craig A.	D	—
2019-07-18	Barbarosh Craig A.	D	—
2019-07-18	Brinkley David L	D	—
2019-07-18	Brinkley David L	D	—
2019-07-18	Brinkley David L	D	—
2019-07-18	Brinkley David L	D	—
2019-07-18	Brinkley David L	D	—
2019-07-18	Brinkley David L	D	—
2019-07-18	Brinkley David L	D	—
2019-07-18	HEINEN ERNST(Chief Development Officer)	D	—

SEC filings: SEC EDGAR

Activity data: SEC EDGAR

ARATANA THERAPEUTICS, INC. — Contributions, Lobbying & Contracts | Poliscope